COVID-19 Pandemic
-
Webinars
COVID-19 & Haemoglobin Disorders: The Impact of Coronavirus on Sickle Cell Disease Patients
An Expert Panel of Six Medical Professionals from various countries, such as India, the UK, Italy and Saudi Arabia, shared their experiences with TIF on the impact of the COVID-19…
Read More » -
Webinars
Accessibility & Affordability of Novel Therapies for Thalassaemia: The Patients’ Perspective
9 patients with thalassaemia, members of TIF’s Patient Advocacy Group for Thalassaemia and Sickle Cell Disease (T-PAG), are discussing with the Thalassaemia International Federation the accessibility and affordability of the…
Read More » -
Webinars
-
Webinars
-
Webinars
COVID-19 & Haemoglobin Disorders: A TIF Webinar with Patient Advocates from Europe
Patient Advocates from Greece, Germany, the UK, the Netherlands, Romania and other countries of the WHO European Region exchange thoughts and opinions with TIF about the daunting challenges and concerns…
Read More » -
News
COVID-19 & Haemoglobin Disorders: The Cyprus Webinar
In the context of TIF’s intensive efforts for the accurate and timely information of individuals with thalassaemia and sickle cell disease (SCD) in relation to the COVID-19 pandemic, the Federation…
Read More » -
TIF Publications
COVID-19 & Haemoglobin Disorders: A Classification of Risk Groups & Other Considerations (2020)
A document seeking to offer a risk level classification for thalassaemia and SCD patients in relation to the ongoing COVID-19 pandemic.
Read More » -
News
TIF’s Latest Guide for the COVID-19 Pandemic is Going Public on the International Thalassaemia Day 2020
As the online celebrations for the International Thalassaemia Day 2020 are at their peak, TIF decided to publish today as a gift to its worldwide patient communities a new guide entitled ”COVID-19…
Read More » -
TIF Publications
Developing Vaccinations & Therapeutic Drugs for COVID-19 (2020)
A list of studies/clinical trials for developing treatments and vaccines for the COVID-19 pandemic. This list is by no means exhaustive, since research in this field is ongoing.
Read More »

